Related Experiment Video
Updated: Jun 10, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
Published on: May 24, 2024
Current and emerging strategies for treating hepatic encephalopathy
Keith J Foster1, Sonia Lin, Charles J Turck
1Surgical Intensive Care Unit, Department of Pharmacy, UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA.
Abstract:
Hepatic encephalopathy (HE) is caused by liver impairment and has a multitude of symptoms in affected patients, including change in level of consciousness, intellectual function, and neuromuscular function. Pharmacologic therapy includes use of nonabsorbable disaccharides (lactulose and lactitol), and antibiotics such as neomycin, paromycin, metronidazole, and rifaximin. Probiotics, acarbose, and drugs such as L-carnitine and flumazenil, may also be helpful in treating HE.
Related Concept Videos
Hepatic Encephalopathy
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pharmaceutical Poisoning: Treatment Strategies
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow